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This thesis explored a novel way to engineer artificial multicellular structures 
combining principles from tissue engineering, cell surface engineering and chemistry.  
Instead of using classical tissue engineering approach, which involves seeding cells 
into polymer scaffold or hydrogels, we tried to work on cell aggregates as building 
blocks for tissue engineering. The one-native cell-surface ketone epitopes produced 
by cell surface modification provides a stable molecular handle for the attachment of 
other molecules to cells. By combining the function of reacting with non-native 
groups on cell surface, and that of linking different cells, we synthesized five different 
kinds of chemicals shown to construct aggregates efficiently. The chemicals within 
defined concentrations have low cellular toxicity. In addition, the size distribution of 
the aggregates can be controlled by concentration and nature of the linkers, such as 
molecular weight. After comparing the aggregation efficiency and the viability of the 
aggregates, PEI-2000-hy was chosen as the model chemical linker for further study.  
 
During the further study of aggregates by PEI-2000-hy, we discovered that this 
method provided a simple and efficient way to build multi-cellular structures, such as 
cell aggregates. Bi-functional chemicals, with the combined functions of biotin 
hydrazide and avidin, were used. Using this one-step linking system, we were able to 
achieve cellular aggregates rapidly and efficiently. In order to find out the important 
factors for the linkers to be an efficient cell glue, neutral tetra-hydrazide was 
 vii
synthesized and found to be non reactive to the modified cells, which distinguished 
the positive charge possessed by PEI as an important factor for PEI-hydrazide to be an 
efficient linker. Besides studying the aggregating ability of this system, we also 
studied its cytotoxicity. Inconsistent with published data, we found that sodium 
periodate oxidation is the most cytotoxic step in this chemical-linking system. 
However, by taking the advantage of charge interaction between the positive linker 
and negative cell surface as well as the specific covalent interaction between ketone 
sialic acids and hydrazide, we were able to form multi-cellular structures using 
relatively low concentration of chemical linker and kept the overall viability of cells. 
In order to further prove the feasibility of this new system, the cell aggregates were 
cultured in suspension, and showed increased viability up to seven days. Fluorescent 
linkers were synthesized and applied in this aggregating system. The ability to 
directly observe the presence of fluorescent linkers on cell surfaces enabled us to 
track the fate of linker. Disappearance of fluorescent linkers from cell surfaces during 
suspension culture hinted us the existence of natural cell-adhesion molecules which 
took over the role of gluing the cells together compactly. 
 
In the initial process of engineering aggregates, we could only control the size 
distribution of aggregates by changing chemical concentrations but not the shape of 
the aggregates. However, in the final stage of the study, we managed to control the 
shape of the aggregates by micropatterning and micromanipulation, which 
demonstrated the possible usage of this system in tissue engineering. 
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Chapter 1 Introduction 
1.1 Tissue engineering 
1.1.1 Overview of tissue engineering 
In the field of tissue engineering, principles of engineering and life sciences are 
integrated to develop biological substitutes that can restore or improve tissue 
functions [1, 2]. Isolated cells or cell substitutes, tissue-inducing substances, and cells 
placed on or in matrices, have been the most general strategies for creating new 
tissues [2]. Engineered tissues can be used to improve burn treatment, dental implants, 
bone, and cartilage transplants, as well as to replace the function of organs such as 
liver and kidney [3]. There are several challenges before these types of treatment are 
fully realized, including finding reliable sources of compatible cells, utilizing the stem 
cells efficiently and differentiating them properly into functional tissue, and 
optimizing the design and fabrication of scaffold. 
 
Tissue engineering usually starts with cells derived from the patient or from a donor. 
According to the specific application, different cell types are needed from different 
sources. For example, articular, auricular, and costal chondrocytes are able to produce 
cartilaginous matrix that forms mechanically bonds with native cartilage, which 
makes them applicable in cartilage tissue engineering [4]. Primary hepatocytes are 
most commonly used in current liver engineering therapies although highly functional 
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hepatocyte cell lines are being developed [5-7]. Besides these mature cell types, 
immature cells in the stem cell stage can also be used [8]. Bone marrow stem cells are 
popular for bone and cartilage tissue engineering nowadays. Recently, people found 
that human embryonic stem cells can rescue injured hear in a clinical trial [9]. In 
addition to cell sources, some kind of 3-D scaffold is required to provide physical 
support for cells to grow outside of the human body. The design and fabrication of 
scaffolds has attracted much attention recently [10, 11]. In order to form hierarchical 
structures, which are similar to native tissues, chemical and mechanical signals are 
also needed at appropriate times and places to induce cellular growth. People 
immobilized galactose, which is specifically targeted to asiaglycoprotein receptors 
(ASGPR), on hepatocytes membrane, on poly (D, L-lactic-co-glycolic acid) (PLGA) 
surface to promote specific cell adhesion [12]. It was also found that the hepatocyte 
functional fate could be engineered in vitro by variable mechanochemical properties 
of the extracellular microenvironment [13], as well as the uses of growth factors [14]. 
 
Applications of tissue engineering can be broadly classified into two types. One is its 
therapeutic application in which the tissue is either grown in a patient or outside the 
patient before it is transplanted [15-20]. The other application is diagnostic 
applications, in which the tissue is made in vitro and used for testing drug metabolism, 
uptake, toxicity, pathogenicity, etc. [21-24]. In both applications, how to cause 
biological tissues to regenerate in vitro is the key problem. Development of this field 
is stimulated by that in gene therapy, polymer science, and cell biology [25]. With fast 
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development of these areas, it is possible that laboratory-grown tissue replacements 
will become a common medical therapy during the early decades of the 21st century 
[26]. However, different from simple cell culture, in which cells reproduce their own 
structure with essential nutrients provided in a proper environment, high level of 
structures must be produced before functional tissue can be constructed [27]. What 
determines cell organization and differentiation in tissues? Is it possible to permit the 
fine control of tissue architecture for the engineered tissues to become clinically 
useful? All of these questions require solving. 
1.1.2 The strategy of Scaffolds and their limitation 
There are many different ways to engineer tissues. The majority one relies on forming 
homogeneous, porous scaffolds that are then seeded with cells [1, 28-32]. These 
scaffolds are traditionally made from polymers, hydrogels, or organic/inorganic 
composites. They play the function of providing the required mechanical support for 
the cells and a frame for growth and differentiation [2, 30]. The overall tissue size and 
shape can be molded by biodegradable scaffolds. Flexibility of scaffold makes it 
possible to optimize the microgeometry for cell recruitment. In addition, the synthetic 
polymer can be controlled to degrade as the tissue forms [33-37]. It is now well 
known that viability and function of surface-attached cells depend on the properties of 
the surface. In fact, synthetic surfaces can be chemically modified to replicate the 
chemical [38, 39] and physical [40-42] features of tissues, rendering materials active 
for specific types of cell populations. Beside proper surface properties, mechanical 
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strength of three-dimensional scaffolds, in most tissue engineering is also required for 
implantation and interconnected channels are essential prerequisites for cell growth 
and nutrients to permeate the entire scaffolding [43-46].  
 
The design of scaffolds for tissue engineering contains several levels, which include 
macroscopic level (on a scale of millimeters to centimeters); an intermediate level 
(hundreds of microns), involving the topography of pores and channels; and the 
molecular level, involving surface texture and chemistry (tens of microns) [10]. 
Current research and development in biomaterials are trying to solve problems across 
these spectrums. Studies of basic biological and biophysical processes at the 
molecular and cellular level, are required so that we understand what processes the 
cells need help with and what events they can accomplish by themselves [47-49]. 
Studies at this end of the spectrum have led to the development of new tools for 
biologists to use in fundamental studies of cell behavior, which in turn lead to better 
bioactive biomaterials. At the other end of the spectrum, scaffolds are needed to direct 
the macroscopic process of tissue formation [50-53]. There are two challenges 
existing. Firstly, the first generation of degradable polymers widely used in tissue 
engineering, was adapted from other surgical uses and has some deficiencies in terms 
of mechanical and degradative properties. New classes of degradable materials are 
being developed [54-56]. The second challenge is how to fabricate these relatively 
delicate polymers into scaffolds that have defined shapes and a complex, porous, 
internal architecture that can direct tissue growth [57-59]. A variety of new 
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approaches are being developed under the classical engineering constraints of cost, 
reliability, government regulation, and societal acceptance. Micropattern and 
computer-based printing techniques, which are among the emerging new strategies, 
will be reviewed in 1.1.3 and 1.1.4 separately. 
 
Despite development of scaffolds for tissue engineering application, there exist 
several problems with this method. The first one is that penetration and seeding of 
cells is not effective enough. Uniformity of cells throughout the scaffold, without 
proper external guiding signals, is also a problem. Although significant progress has 
been made in designing scaffolds that enable effective seeding and cell migration [60], 
it is still far from optimal. The second problem is that natural organs usually contain 
many cell types, and it is a challenging technical problem to place different cell types 
in defined positions [61, 62]. The third problem is that different types of scaffold are 
required for engineering tissues which differ in properties. Besides the above 
problems, the absence of vascularization is the key problem for solid scaffold larger 
than 200 um. Currently, many scientists are trying to use different ways to construct 
the vascularization tissue [52, 63-66]. 
1.1.3 Micropattern in tissue engineering   
Function of tissue is modulated by the spatial organization of cells on a micrometer 
scale. So it is quite important to engineer tissue to replicate natural cellular structures 
so that we can understand, simulate and measure their in vivo functions. However, 
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selective attachment of cells on surface has always been a technological challenge. 
People tried severaldifferent ways such as scratched extracellular matrix pattern [67] 
to guide attachment, spreading and migration of cells. Recently the silicon 
microfabrication techniques and development in surface chemistry made it possible to 
design the biochemical composition of substrate [68, 69], the matrix surrounding a 
cell [70, 71] and the cell type contacting each other [61, 62]. Normally a template to 
which cells attach preferentially is microfabricated before the selective cell 
attachment is achieved. The template can be made of metals [72], self-assembled 
monolayers [73], polymers [74], extracellular matrix proteins [75] or cell adhesive 
peptides [76].  
 
An alternative to this template-based pattern is to deliver cell suspension onto specific 
regions of a substrate by microfluidic channels [77, 78]. However, this method can 
only be applied to a few cell types with slow metabolism. Another alternative way is 
to use a stencil, which is a thin sheet containing holes of specialized shapes and sizes. 
Metallic stencils were micromachined to generate cellular micropatterns as early as 
1967 [79]. However, the difficulty of metallic to seal against the substrate and the 
challenge involved in fabrication of metallic stencils with diameters around 10-15um, 
the size of single cell prevents the further application of metallic stencils [80]. More 
recently, people have successfully made cellular patterns of many adherent cell types 
through the fabrication of Poly (dimethylsiloxane) (PDMS) stencil [81]. The stencil 
can be applied to cell culture substrate before cell seeding and peeled off manually 
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after seeding. The stencils can be replicated many times from the same master since 
the replication process does not damage the mold, which make precise repeatability 
possible over large surface areas. 
 
A common drawback of all these methods mentioned above is that they are 
topologically constrained to two-dimension. In order to reproduce tissue structure 
functional in three-dimension, people tried to fabricate three-dimensional microfluidic 
structures by stacking membranes in PDMS using proto-typing [82-84]. Although 
fabrication 3D PDMS mold is much more complex than fabricating simpler structures, 
this is a versatile technology to pattern multiple types of cells or proteins in complex 
continuous surface. Since tissues of mammalian organisms always exhibit 
complicated micro-architecture related with different cell types, the ability to pattern 
different cell types in 3D defined structures paves the way to study the relationship 
between function and structure of tissue in single cell resolution.  
1.1.4 Organ printing – a novel approach in tissue engineering 
Besides micropattern to control the shape of engineered tissue in vitro, methods to 
print patterns and structures of scaffold are worked out recently as novel ways to 
replace traditional techniques in tissue engineering [85]. Computer designs are 
utilized in some approaches to fabricate complex 2-D and 3-D structures directly from 
the basic elements. Several different printing technologies have shown the ability to 
create porous polymer scaffolds with both macroscopic and microscopic structures 
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[86]. However, seeding cells in these scaffolds only leaves a homogeneous mass of 
cells which does not resemble the heterogeneous structure of tissue. There are some 
more advanced methods of cell seeding which possibly could place different types of 
cells and biomaterials into the scaffold in organized patterns. They could thereby 
create heterogeneous constructs [87, 88]. One possible way to accomplish this seeding 
approach would be using a tool to print cells into single layers of scaffolds, then the 
entire tissue-like constructs can be built by using a layer-by-layer approach [88]. 
 
Based on the concept of printing cells, several researches have been done during the 
past few years. Previous experiments have been done to demonstrate that embryonic 
chick spinal cord cells could be printed to a substrate using a laser guidance machine 
[89, 90]. In addition, both prokaryotic and eukaryotic cells were shown to remain 
viable after printing cell patterns with a modified laser transfer technique [91]. A 
recently modified ink jet machine was used to print patterns of bovine aortal 
endothelial cells [92-94]. All of these above techniques have the ability to enhance the 
traditional cell-seeding process in tissue engineering by placing single or multiple cell 
types into scaffolds precisely controlled by computer. 
 
Until recently, this technology of printing cells was limited to the printing of 2D 
tissue constructs. A new opportunity for extending the printing technology to three 
dimensions is created by the emerging use of thermo-reversible gels [95]. The gels, 
which are nontoxic, biodegradable, thermo-reversible, can be used as a sort of “paper” 
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and the cells are used as the “ink.” 3D constructs could be generated by dropping one 
layer of gel onto another layer of gel, which has already been printed with cells. This 
technology termed “organ printing” [92, 94] enables complex 3D organs with exact 
placing of different cell types to be printed in a few minutes. Previous work also 
showed that cell aggregates which are placed closely in a 3D gel can fuse into 
structure defined by initial location of the aggregates [96]. This proves the feasibility 
of this method in the area of tissue engineering.  
1.2 Cell Aggregates  
1.2.1 Reaggregate approach in tissue engineering 
Regeneration of simple animals and whole vertebrate tissues was achieved in 
reaggregation experiments several decades ago [97]. It is attempted to regenerate 
more or less complete tissues or organs from dispersed cells of a particular origin 
under specifically controlled culture conditions. The technique includes dissociation 
of tissue enzymatically or mechanically, reaggregating of the dispersed cells into 
multi-cellular spheres by rotation in suspension, and culture of spheres in regular 
culture dishes, spinner flasks, or in conical tubes within roller drums [98, 99]. 
Suspension cultures of 3D spheres allow tissue growth in all three dimensions [100]. 
It was also found that compared with cells in monolayer cultures, the cells in 
3D-spheres have higher proliferation rates and their differentiation more closely 
resembles that in situ [101-103].  
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1.2.2 Previous way to get aggregates 
 One of the oldest ways that 3D spheroids of cells can be obtained is by spontaneous 
cell aggregation, which can generate somehow spherical cellular structures or by 
culturing cells on artificial substrates that induce cellular differentiation and maintain 
cellular function. Malignant cells are able to adhere to each other to form homotypic 
aggregation [104] or adhere to other cells resulting in heterotypic aggregation [105]. 
However, because of mass transportation limit, accumulation of metabolic waste and 
lack of nutrient becoming progressively serious deep within the spheroid, most of the 
proliferating cells were present on or near the surface [106]. 
 
For cells in suspension to grow as 3D aggregates or spheroids, it is required that the 
adhesive forces between the cells are greater than that between cells and the substrate 
the cells are cultured on. The simplest way to prevent adherence of cells to substratum 
is to use liquid overlay technique, which prevents deposition of matrix [107]. Using 
this method, spheroids are formed following a biphasic process. In the first phase, 
cells migrate towards each other on the substratum and aggregate into spheroids, 
whereas in the second phase, cell growth results in the increase of spheroid size [108, 
109]. In order for spheroid to form in this way, different substratums are required for 
different types of cells. For example, primary hepatocytes spheroid can be formed by 
culturing cells on positively charged surfaces or dishes coated with an extracellular 
matrix protein such as proteoglycan [110], poly-(2-hydroxyethyl methacrylate) [101, 
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111], or poly-N-isopropyl acrylamide [112]. Breast cancer cells are grown over an 
agar base or reconstituted basement membrane [107].  
 
Liquid overlay cultures in static environment are useful in studying individual 
spheroids, whereas spinner flasks are used to provide dynamic suspension when 
greater numbers of spheroids are cultivated. Spinner flasks are stirred tank bioreactors, 
in which mixing of impeller keeps the cells from settling down. The movement of 
fluid theoretically plays the role of assisting mass transportation of nutrients and 
wastes into and out of the spheroids separately [113]. Although the most widely used 
method for culturing large numbers of multicellular spheroids was spinner flask 
culture [114], roller tubes and gyratory shakers were also used somehow successfully. 
People found that 80% of hepatocytes can form spheroids within 6hrs of spinner 
culturing, which is much faster than previous methods, which normally take 24hrs to 
96hrs [115].  
 
Rotary Cell Culture System was developed by NASA and it introduced a 
revolutionary concept [116, 117]. In this system, cells are maintained in a dynamic 
suspension in liquid media mixed by small hydrodynamic forces. Fluid turbulence and 
shear forces are minimized in this system, in which the vessel is completely filled 
with media and there is a semi-permeable membrane to eliminate bubbles. This 
system successfully integrates co-localization of cells, 3D cell-cell interactions, 
cell-matrix interaction and minimal shear forces, which provides a mild environment 
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for 3D spheroid cell culture with adequate mixing for mass transportation. This is a 
great advantage as higher fluid turbulence in the spinner flask was shown to damage 
fragile animal cells and affect the integrity of membrane as well as normal 
metabolism [118].  
 
Other methods used by previous people to get cell aggregates include scaffold-based 
culture and hanging drop method. Hepatocyte-like spheroid structures could form in 
three-dimensional peptide scaffolds from putative liver progenitor cells [119]. 
Hydrogel-coated textile scaffolds was also found to be a good candidate in liver tissue 
engineering as they permit favorable hepatocytes attachment, spheroid formation and 
thus the maintenance of function [120]. The recent emergency of hanging drop 
method provides a mild, straightforward way to produce spheroids of homogeneous 
size, which are applicable to many anchorage-dependent cell types [121, 122].  
1.2.3 Previous application of cell aggregates 
Previous application of reaggregates experiments can be divided into two types 
according to time scale, short-term experiments, which last from minutes to a few 
hours and long-term ones which last from several hours to a few days. Short-term 
reaggregation has been used widely to analyse cell–cell interactions, cell surface 
properties, and to characterize cell adhesion molecules [123-125]. The reaggregate 
approach in longer time scale allows study of the formation of tissue-like cell 
arrangements. However, reaggregate approaches do not have a cellular pattern from 
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which the tissue originates [126]. Thus, a primary goal of the reaggregate approach is 
not to simulate normal tissue formation but to reveal basic mechanisms involved in 
this process. Take the aggregates formed in monolayer cultures for example, the 
reaggregate approach enables us to follow the process of tissue formation from single 
cells to organized spheres in a controlled environment so that we can understand 
better the inherent principles of tissue formation [127]. 
1.3 Cell surface engineering  
1.3.1 Introduction to cell surface 
The cell membrane of mammalian cells contains several different components, 
including lipids, proteins and carbohydrates. These components are constructed to 
generate the sophisticated functions of the membrane, such as uptake of molecules 
selectively into the cell, specific communication between cells as well as that between 
cell and extracellular matrix [128]. Besides its complexity, the cell membrane is also a 
dynamic structure that changes its chemical constituents and its overall composition 
from time to time according to the change of its environment. One example is that 
during tissue development it is by changing carbohydrate and protein handles on the 
outer plasma membrane that the individual cell influences tissue morphogenesis. 
Because of the heterogeneity of cell membranes, they become a challenging 
environment in which non-native chemical species are introduced. In addition to this, 
chemical modification on the cell surface should be insured not to induce undesirable 
changes in cell behaviors, which further complicates the area of cell surface 
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engineering. Despite the difficulties, there has been rapid progress in this area, in 
which scientists have explored several types of chemical strategies to engineer cells 
surface, such as insertion of molecules into cell membrane, reactions using exogenous 
enzymes, inhibition of metabolic pathway, metabolic engineering and covalent 
ligation to cell surface chemical groups. 
1.3.2 Chemical strategies to engineer cell surfaces 
The first type of chemical strategy to engineer cell surface is insertion of molecules 
into cell membranes. A number of groups have successfully displayed both naturally 
occurring and synthetic bioactive molecules on the cell surface by employing the 
lipophilic nature of mamamliam cell membrane. To achieve this goal, a fatty moiety 
is attached to the biomolecule of interest and it incorporates into the membrane when 
the reconstructed molecule is applied to the cell, leaving the biomolecule exposed on 
the cell surface. Two main classes of fatty compound have been used for this 
application, which are named GPI-anchored proteins [129, 130] and 
cholesterol-tethered compounds [131]. Protein transfer using these fatty anchors has 
great potential for pathogenic study of disorders and diseases where cell surface 
molecules are aberrant.  
 
Enzymes are widely used in the process of glycosidic bonds formation in 
carbohydrate chemistry, which renders the use of enzyme-catalyzed chemical 
transformations as a feasible alternative approach to traditional ones. Applying 
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exogenous glycosyltransferase, such as fucosyltransferases [132] and 
sialyltransferases [133] on the existing surface glycoforms and with an appropriate 
activated sugar donor can be performed on the cell surface. However, the exogenous 
application of tolerant glycosyltransferases has been replaced to a certain extent by 
the utilization of endogenous metabolic machinery for cell surface engineering. 
 
Because the glycosylation of proteins and lipids is an important factor influencing the 
molecular complexity and functionality of the cell surface, inhibition of carbohydrate 
metabolism presents an alternative chemical strategy for engineering cell surface. 
Diverse complements of enzymes are required for a monosaccharide to be converted 
into an active sugar donor [134, 135]. This enables the inhibition of specific enzymes, 
which thereby makes it possible to subtly change the surface glycosylation. The 
development of inhibitors for selective glycosylation will be useful for a number of 
therapeutic applications, including treating cancers and autoimmune diseaseas. 
Natural products have become the resources of some inhibitory molecules, such as 
carbohydrate mimetic alkaloids from plants and microorganisms [136]. Specifically 
designed synthetic drugs are important additions to those natural occurring inhibitors. 
Most inhibitors exert their effects by competing with the natural enzyme substrates, 
which can be sugar donor or acceptor species, and acting as transition state analogues 
of the enzyme–substrate complex. 
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Some enzymes involved in the biosynthesis of cell surface molecules are tolerant to 
their substrates structural variability. It makes metabolic engineering an alternative 
strategy for altering the chemical functionality of cell surfaces. Technically, unnatural 
precursors of cell surface moieties can be used to incubate cells followed by taken up 
and metabolized by the cells. Then unnatural structure will be incorporated on the cell 
surface. One example of this strategy is the incorporation of unnatural sialic acid into 
cell surface [137-139]. This approach has been used on different cell types to alter the 
structure of sialic acids on cell surface, which has potential therapeutic applications 
because changing the structure of the sialic acids will possibly affect cell recognition 
and adhesion events. 
 
Besides the four techniques mentioned above, there is another type of strategy for 
modifying the chemical structure of cell surfaces, which is utilizing direct covalent 
reaction. There are two different ways to achieve this. The first one is reactive 
molecules can be ligated directly to cell surface natural generating functional groups, 
such as amines or thiols. The other approach involves generation of non-native 
functional groups on the cell surface, which can react specifically with the molecule 
of interest.  
 
Although it was found that it is not easy to alter the behaviour of living cells by 
labeling cells with reactive molecules on cell surface functional groups, previous 
work suggested that this might be a viable technique in the area of tissue engineering. 
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It was found that by encapsulating the implanted cells with a biocompatible polymer, 
such as poly (ethylene glycol) (PEG), the chance for the implants to be recognized 
and destructed by host immune cells was reduced [140, 141]. Since functional group 
on PEG can reactive with amines exposing on cell surface, cells can be completely 
surrounded by PEG molecules and viability and normal functions of the cells are not 
be affected compared with untreated cells. However, the major drawback of this 
approach is that there is no specificity between cell surface functional groups and 
reactive molecules. To solve the problem above, another approach can be used for 
engineering the molecular on cell surface, which is to generate unnatural functional 
groups at specific sites of the cell surface molecules. These reactive groups don’t 
normally appear on the cells surface, so they can be used to chemoselectively ligate 
suitably functionalized molecules. Two different types of chemical groups, reactive 
carbonyls, which are usually in the form of aldehydes and ketones, and azides are the 
focus of current research. Aldehyde and ketone groups on the cell surface can 
selectively reacted with hydrazide, aminooxy or thiosemicarbazide functionalities 
[142]. Three different ways have been used to incorporate these functional groups into 
cell surface, including application of exogenous enzymes, direct chemical reaction 
and metabolic engineering. 
 
The first method used to introduce aldehyde groups at specific sites in cells surface is 
the application of exogenous galactose oxidase, which oxidizes terminal galactosyl 
and N-acetylgalactosaminyl residues. Compared with this exogenous enzyme method, 
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there is a simpler one for the introduction of aldehydes, which is direct oxidation of 
sialic acids with sodium periodate [143]. This method is very rapid and it was found 
to be concentration dependent, which is selective for the sialic acid when mild 
conditions are employed [144, 145]. Although it is a bit crude technique, it has been 
demonstrated that aldehyde groups can be incorporated into the cell surface by mild 
sodium periodate oxidation, which did not affect the viability, or morphology of the 
cells [146]. Besides these two methods, the delivery of modified sialic acid to cell 
surface by metabolic pathway is also a powerful technique for cell surface 
engineering. Ketone and azide groups could be delivered to cell surfaces in this way 
by employing functionalized mannosamine derivatives, such as 
N-levulinoylmannosamine (ManLev) and N-azidoacetylmannosamine (ManNAz) 
[147, 148]. Although ketones and azides could be effectively metabolized into sialic 
acids on cell surface in numerous cell types without adverse effects on the viability of 
cells, the level of ketone expression on cell surface depends on the species of cells. It 
is possibly because in different cell types, the tolerances of the enzymes in the sialic 
acid metabolic pathway to structural variations are also different. 
1.3.3 Applications of surface engineered mammalian cells 
Cell surface interactions are of fundamental importance to the functions of cells and 
tissues both in vivo and in vitro, whereas cell surface modification may probably 
affect cellular functions. This fact makes the various available strategies of 
engineering mammalian cells surface have a wide range of applications, especially in 
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the research area of pharmaceutics and biomedical engineering. They can be divided 
into two categories, drug delivery, tissue engineering and cell based strategies.  
 
1.3.3.1 Drug delivery 
One of the key issues to be solved in drug delivery is how to deliver drugs to a 
particular cell type and organ without specific receptors on cells or transport 
mechanisms for the drug. Chemically engineering cell surfaces provides a way to 
facilitate the specific interactions between cell surface and drugs or drug delivery 
systems. For example, synthetic adenovirus receptor was incorporated into cell 
surface by metabolic engineering to potentially enable gene therapy [149]. Recently, 
synthetic receptors for exogenous proteins were specifically introduced into cell 
surfaces to specify the permeability of cell membrane to large drug molecules [150]. 
In addition, tumor cells could also be tagged by incorporation of unnatural sugar 
residue into the sialic acid molecules on the cell surface, which provided a strategy for 
selectively killing tumor cells [151]. 
 
1.3.3.2 Tissue engineering and cell-based therapies 
Cell-cell interaction and cell-matrix interaction are quite important factors for the 
development or repair of tissue. Since both of them are controlled by cell surface 
properties, cell surface engineering is potentially useful in the field of tissue 
engineering. The major problem with transplantation of a tissue or organ from a donor 
to a patient is the immune rejection of the tissue or organ by the host. Cell surface 
engineering provides a way to prevent foreign cell or tissue being recognized by 
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immune system. For example, pancreatic islets have been encapsulated in poly 
(ethylene glycol) (PEG) to block the binding of immune cells to the foreign tissue 
[140]. Cell surface engineering was also found to assist nerve regeneration, especially 
spinal cord. Büttner et al. have shown that the length of neuritis, the surface of which 
were metabolically engineered, can be more than twice compared to control cells 
[152]. Besides the application above, it was also found that cellular aggregation could 
be induced by cell surface engineering [146]. Since three-dimensional reconstruction 
of tissues is the ultimate goal for tissue engineering, this finding provides an 
important approach in this area. 
1.4 Application of Poly (ethylenimine) and dentrimers in 
bioengineering 
The beauty of chemistry is that we can design and synthesize chemicals with required 
properties in various applications, such as scaffolds in tissue engineering, vectors for 
gene delivery, carriers for drug delivery etc. In the following section, the primary 
chemical, poly (ethylenimine) and dentrimers used in this project will be introduced 
to illustrate their chemical properties and biological applications. 
1.4.1 Chemistry of Poly (ethylenimine) and dentrimers 
Poly (ethylenimine) (PEI) has been used for many years in common processes 
including paper production, shampoo manufacturing and water purification. There are 
two forms of the polymer: linear and branch [153]. Both of them are produced by 
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cationic polymerization from two different kinds of monomers, aziridine monomers 
for branched one and 2-substituted 2-oxazoline monomer for linear one (as shown in 
Fig 1) [154]. The standard form of PEI for gene transfection is branched PEI, which 
shows significantly higher transfection efficiency. 
 
The basic unit of PEI has one nitrogen atom following every two carbons. In branched 
PEI, there are primary, secondary and tertiary amino groups, both of which can be 
protonated, rendering PEI as the organic macromolecule with the highest 
cationic-charge-density potential [155]. PEI has an effective buffering capacity at a 
broad range of pH value, which is closely related to its high efficiency in gene 
transfection [155].  
 
The word “dendrimer” came from the Greek dendron and meros which mean ‘tree’ or 
‘branch’ and ‘part’ separately. ‘Arboroles’ or ‘cascade polymers’ are also used to 
name “dentrimer” [156]. Dendrimers are well-defined chemicals, with a low 
polydispersity compared with traditional polymers. The dendritic branching results in 
semi-globular to globular structures, mostly with a high density of functionalities on 
the surface together with a small molecular ‘volume’. 
 
The dendrimer design can be based on a large variety of linkages, such as polyamines 
(PPI dendrimers) [158], a mix of polyamides and amines (PAMAM dendrimers) [159] 
and more recent designs based on carbohydrate [160] or containing ‘third period’  
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Fig 1.1 Stuctures of PEI percursors and end products. Adapted from [154]. 
 
 




elements like silicon or phosphorus [161]. Dendritic structures are chemically 
synthesized by two different approaches, either divergent or convergent. In the 
divergent approach the dendrimer is synthesized from the core and built up generation 
by generation [162]. The alternative convergent approach starts from the surface and 
ends up at the core, where the dendrimer segments are coupled together [163]. 
 
The structure of dentrimers can be divided into three parts: the multivalent surface, 
with a high number of potential reactive sites, the ‘outer shell’ just beneath the surface 
having a well-defined microenvironment protected from the outside by the dendrimer 
surface, and the core, which is protected from the surroundings in higher generation 
dendrimers, creating a microenvironment surrounded by the dendritic branches [164]. 
The three parts of the dendrimer can be tailored specifically for the desired purposes. 
For example, the multivalent surfaces on the dendrimer can contain a large number of 
functional groups, making the dendritic surfaces suited to multivalent interactions 
which are important in biological systems [165]. 
1.4.2 Biological application of PEI and dentrimers. 
Since transfection was first introduced as a technique in mammalian cells in 1966 
[166], both viral (adenovirus and retrovirus) and nonviral carrier systems have been 
used to treat several genetic diseases, such as cystic fibrosis [167-170] and several 
kinds of cancer [171, 172]. Although viruses have been the most popular vectors for 
gene delivery, there are several problems when viral vectors are used in clinical 
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treatment, for example, the transfection efficiency in vivo is restricted due to the 
inflammatory properties of viruses; inappropriate tropisms prevent them to target 
tissues [173]. Non-viral vectors with low immunogenicity have been investigated as 
alternatives for viral vectors. Cationic polymers with large diversity of structures and 
molecular design can be recruited to produce vectors with different properties [174]. 
These designed polymers, such as poly (L-lysine) are able to condense DNA into 
discrete particles through electrostatic interaction and stabilize the polyplexes by 
enclosing it with hydrophilic coating. Positively charged polyplexes interact strongly 
with cell membrane which is negatively charged followed by taken up by the cells 
through endocytic pathways [175].  
 
However, the efficiency of non-viral vectors to transfect cells has yet to be improved 
which is mainly because a large fraction of the polyplexes from cationic polymers and 
DNA are delivered into lysosome and degraded there finally. Fortunately, some kinds 
of polymers, such as Poly (ethylenimine) (PEI) [153, 155] and dentrimers [176-178], 
can mediate gene transfection with relatively high efficiency. Abundance of secondary 
and tertiary amino groups in these chemicals prevents the lowering of pH in 
endosomes and lysosomes, preventing degradation of polyplexes. These polymers 
also induce osmotic swelling of the endosome and lead to the rupture of endosome, 
followed by releasing DNA into cytoplasm [179, 180].  
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Besides the potential application of dentrimers in gene transfection, significant 
advances have been made in the synthesis and study of glycodendrimers and peptide 
dendrimers in the past few years. Application of these dendrimers has facilitated the 
understanding of the study of carbohydrate–protein and protein–protein interactions. 
For example, glycodendrimers with surface carbohydrate units have been used to 
study the protein–carbohydrate interactions that are implicated in many intercellular 
recognition events [181, 182]. Dendrimers with surface peptides or amino acids 
incorporated into the framework as branching or core have potential applications as 
protein mimics, antiviral and anticancer agents, vaccines and drug delivery systems 
[183-185]. 
1.4.3 Cytotoxicty of PEI and Dentrimers 
Both PEI and dentrimers were reported to be toxic to cells. It was found that PEI was 
involved in causing lysosomal disruption in rat hepatocyte when the concentration of 
PEI amines is 0.001 M. However, the stability of lysosomes were not affected when 
the concentration of PEI is at or below 0.0002 MAmine [186]. Fusogenic effects of both 
linear and branched PEI on liposomes have been reported, which showed that 
branched PEI disrupting liposomal membranes made from phosphatidyl serine, 
whereas the effect was not great when the liposomes were constructed from 
phosphatidylcholine / phosphatidyl serine [187]. These results collectively suggested 
that low concentration of PEI will not harm plasma membranes. After PEI polyplexes 
was systemically delivered in vivo, PEI could induce multiple cellular responses such 
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as apoptosis [188]. Systemic application of linear PEI polyplexes in mice led to liver 
necrosis, activation of lung endothelium, adhesion of aggregated platelets and shock 
after injection of elevated doses [189].  
 
Generally speaking, amino-terminated dentrimers are cytotoxic [190]. Studies on 
rodent muscles showed that amino-terminated PAMAM dentrimers was more 
myotoxic than cationic liposomes and proteins [191]. In addition, both 
amino-terminated PAMAM and PPI dentrimers show a molecular size dependent 
increase haemolytic effect on a solution of rat blood cells [190]. Recent comparative 
studies of anionic and cationic PAMAM dentrimers conclude that carboxyl 
functionlized PAMAM dentrimers are less toxic than amino-terminated one [192]. 
From the few systematic studies on the in vivo toxicity of dentrimers, injection of 
PAMAM dentrimers with 10 mG/kg concentration do not appear to be toxic, 
independent on the dentrimer surface properties [193] 
 
The reason for toxicity of PEI and dentrimers to cells is probably because of the 
favored interactions between negatively charged cell membranes and the positively 
charged polymer surfaces, which enables the polymers to adhere and damage the cell 
membrane and cause cell lysis.  
1.5 Project outline 
Classical tissue engineering involves seeding cells into polymer scaffold or hydrogels, 
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culturing the cells-scaffold composite for a period of time followed by transplanting 
the tissue into recipient body. However, there are several problems with this method, 
including ineffective cell seeding, difficulty involved in placing different types of 
cells in scaffold and absence of vascularization. An alternative way is to use cell 
aggregate instead of individual cells as building blocks for tissue engineering. 
Traditional way to get cell aggregates was to use cell adhesion molecule, which was 
uncontrollable and usually takes several days. An alternative way is to use 
biofunctional molecules [194, 195]. However, those molecules always target cell 
surface proteins, which are important in intracellular signal transduction. Modification 
of oligosaccharides, which are not directly correlated to cellular functions, provides 
an alternative approach for aggregation formation. Sialic acid on the top end of 
glycoprotein was oxidized and made to react with biotin hydrazide. Subsequently, 
avidin was added to achieve multicellular structure. However, it takes a relatively 
long time for the aggregates to be formed by this 2-step reaction. Since the reactions 
all took place in non-physiological environment, it is imperative to shorten the length 
of time for aggregation formation so as to keep the viability of cells in aggregates.  
 
In order to reduce the time required for cell aggregation and to promote general usage 
of this technique, we would like to design special chemical linkers using conjugation 
method. Instead of treating the modified cells by two-step reaction, we synthesize 
bi-functional chemical linker with at least two hydrazide groups, which shortens the 
time for multi-cellular structures to be formed. We try to synthesize different types of 
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chemical linker in the first part of this work and one of them will be selected out as 
the model for further study of this aggregating system. Cytotoxicity test, which shows 
the toxicity of the chemical to cells, aggregation efficiency analysis, as well as live 
and dead assay, which characterizes the overall effect of this linker on viability of 
cells in aggregates, will be used as the parameters to choose the best chemical for 
further study. In the second part of the work, the factors affecting the aggregating 
ability of the chemicals are to be studied to explore the advantages and mechanism of 
this system. In order to prove the feasibility of this system as an alternative approach 
for generating tissues in vitro, the aggregates will be cultured in suspension up to one 
week. The viability and functionality changes will be tracked. Fluorescence tag is also 
conjugated to the chemical linker and used to track the fate of chemical linkers in 
aggregates, which may stimulate further study on understanding the aggregate 
formation and changes during culture. In order to find out whether this aggregating 
approach can be performed in a more controllable way, we try to combine this 
technique with micropatterning and micromanipulation to control the size and shape 
of the multi-cellular structures, which may further prove the possible profound use of 
this system in regenerating 3D tissues in vitro. 
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Chapter 2 Preliminary study of chemical linkers for 
aggregates formation 
2.1 Cell surface modification detected with streptavidin - FITC 
As mentioned in the work done by Oetke and his group members [146], sialic acids 
on myoblast cell surfaces could be oxidized into non-native aldehyde groups. The 
modification could be detected by biotin hydrazide and streptavidin – FITC either by 
confocal laser scanning microscopy or by flow cytometry. They also assessed the 
persistence of cell surface modifications on myoblast cells after 24 hours of culture 
and found that cells retained the aldehyde groups at a reduced level corresponding to 
27.6 ± 2.2% of the initial aldehyde group number. Similar results were obtained when 
this was repeated with biotinylated cells. In our experiment, we used confocal laser 
scanning microscopy to detect the surface modification as well as tracking the 
persistence of non-native aldehyde groups on HepG2 cells. After modification, we 
cultured the cells up to 3 days and tracked the presence of aldehyde groups on the cell 
surfaces. Inconsistent with published data, we found that the aldehyde groups only 
stayed on cell surface for one day after modification (Fig 2.1, B,C,D), whereas the 
biotinylated ones persisted for 3 days (Fig 2.1, E,F,G). It is possible that the free 
aldehyde groups on cell surface are more easily to be endocytosed, whereas the 




Fig 2.1 Distribution of non-native aldehyde groups on HepG2 cells after modification 
observed by Olympus Fluoview 300. The excitation wavelength is 488 nm. The cells 
were modified with 1 mM NaIO4 for 15 minutes, followed by biotinylation and 
stained with Streptavidin-FITC (green). The cells were imaged using confocal laser 
microscopy. Cells were biotinylated and stained immediately after modification (A) or 
cultured for 1(B), 2(C), 3(D) days separately after modification and before 
biotinylated and staining or cultured for 1(E), 2(F), 3(G) days after modification and 



















2.2 Synthesis of various types of chemical linker 
Biotin hydrazide and avidin were used to aggregate cells by Debank, P.A et.al 
[146].When this system was tried at the early stage of the work, it was found that this 
way of aggregating cells involve so many steps that we could not obtain satisfactory 
cell aggregates after several months of optimization In addition, cells were placed in  
non-physiological conditions for several hours. Due to these disadvantages, we 
designed several types of chemicals which can aggregate the cells rapidly.  
 
Polyethylenemines [155] and dentrimers [176] have been used widely in the area of 
gene delivery for several years, taking advantage of their cationic properties. They 
were chosen as the backbones for the hydrazide chemicals because of their abundance 
of amine groups, which can be easily modified into other functional groups. Reaction 
is performed in aqueous environment and involves two steps (Fig 2.2). In the first step, 
PEI and dendrimers, which bear many primary amino groups reacted with 
2-iminothiolane [196] resulting in the product with sulfhydryl groups. 2-iminothiolane 
(2-IT) is normally used to incorporate thiol groups into proteins by reactions of amino 
groups (Fig 2.2) [197]. EMCH in the second step reaction contains both maleimide 
groups and hydrazide groups [198]. The maleimide group reacts specifically with 
sulfhydryl groups at neutral pH to from a stable and non-reversible thioether linkage. 
Maleimide reacts with sulfhydryls 1,000 fold faster than with amines at neutral pH, 
the reaction favors primary amines at pH > 8.5. Since all the original chemicals used 




Fig 2.2 Reaction scheme of 2-iminothiolane and amino group. Adapted from [197]. 
 



































































conjuage one or more sulfhydryl groups, which will be replaced into hydrazide groups 
by EMCH , resulting in the molecules with at least two hydrazide groups. 3 types of 
Dentrimers with 4, 8 and 16 arms separately and 2 types of PEI with molecular weight 
of 600, 2000 were used as the initial chemicals for synthesizing the linkers. We named 
the two series of hydrazide linkers as DAB-AM-4/8/16 iminothiolane-hydrazide and 
PEI-600/1200 iminothiolane-hydrazide separately. Using this protocol, we were able 
to get product with reproducible NMR spectrum (not shown here), from which we can 
see the distinct differences between the final products and the initial reagents. Due to 
the time limit, NMR data was not analyzed elaborately. So we are not sure how many 
hydrazide groups are on each molecule, which requires further characterization. 
2.3 Cytotoxicity of chemical linkers 
The effect of PEI and dentrimers on mammalian cells have been discussed by many 
previous papers [186, 187, 199, 200]. However, cytotoxicity of the hydrazide 
chemicals, which were seldom synthesized and characterized, was not tested before. 
In order to assess the cytotocity of the chemicals, we used MTS assay to test and 
compare the effects of the different types of chemical linkers. Cells were incubated in 
different concentrations of chemical solution in serum free DMEM followed by 
incubation with MTS for 4 hours. By correlating the number of live cells with the 
absorption of the resultant solution, we calculated the percentage of live cells under 
different conditions.  
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From results in Fig 2.4 we found that for the same series of chemicals, take 
DAB-iminothiolane-hydrazide as an example, the cytotoxicity of the chemical 
increases as the molecular weight increases. It is possibly due to the increased number 
of amino groups on the molecule. This is also in accordance with the general finding 
that increasing molecular size of polymers may result in increased cytotoxicity [201]. 
When all of the five types of hydrazide chemicals are compared, 
DAB-AM-16-iminothiolane-hydrazide shows the highest toxicity to HepG2 cells in 
MTS test. It is probably because this chemical bears most primary amino groups, 
which increases the chance for the cationic chemical to adhere to cellular surface and 
cause cell lysis. Although we are not sure how many hydrazide groups are on each 
molecule for these five types of chemicals, from NMR data, we can estimate that only 
a small part of the amino groups on the original multi-amino chemicals were 
converted into hydrazide groups. So most likely, the factor that decides the 
cytotoxicity of the chemical is still the structures of the original chemicals. 
2.4 Ability to aggregate cells 
All of the chemicals mentioned above act successfully as chemical linkers, which are 
shown in Fig 2.5. For the DAB-AM-iminothiolane-hydrazide and PEI-iminothiolane- 
hydrazide synthesis, both of these two categories of linkers function well, whereas all 
of the original chemicals cannot aggregate cells using the same condition. It seemed 
to us that if we can really synthesize chemical linker with all of the molecules fully  
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Fig 2.4 The cytotoxicity of chemicals tested by MTS assay. Five different 
concentrations of each chemical were added into 96-well plate. The viability of the 
cells was calculated based on the absorption of the resultant solution. A. cytotoxicity 
test of the four kinds of DAB-AM-iminothiolane-hydrazide. B. cytotoxicity of the two 
kinds of PEI derived hydrazide.  
 
 
conjugated, the concentration of the chemical for aggregation could be lowered 
further down to micro scale. From all of images taken, we can also conclude that it is 




branch-like structures. In addition, the size of the aggregates in the same sample is 
also not uniform (Fig 2.5). 
 
When all of the chemicals were applied to aggregate cells, it showed that all five types 
of chemicals synthesized from dentrimers/PEI, 2-iminothioalne and EMCH can 
aggregate cells rapidly, whereas the original chemicals without hydrazide groups 
cannot. So the key player for the formation of cellular aggregates by chemical linkers 
should be the conjugated hydrazide group, which can react specifically with ketone 
groups on the modified cell surface. Since all of the five chemicals have several 
amino groups on each molecule, even only a part of them can transverse into 
hydrazide groups, it is still possible that some of the molecules after reaction will bear 
more than one hydrazide groups, enabling them to act as linkers. 
2.5 Size distribution of aggregates  
Fig 2.5 shows that cell aggregates can be formed by all of the five kinds of 
synthesized chemicals. However, our aim of this project is not only to get cell 
aggregates but also to control the size and shape of the aggregates. Can we achieve 
this by using this rotating system? In order to answer this question, we tried to 
quantify the size of aggregates formed by chemical linkers in rotating tubes. We used 
three different concentrations for each type of chemical. At the end of experiment, 
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Fig 2.5 Cell aggregates by different kinds of chemical linkers. Cells were modified by 
1 mM NaIO4 in dark at 4 oC for 15 minutes, followed by incubated in different 
chemical solution for 30 minutes. A: 1 mM DAB-AM-4-iminothiolane-hydrazide.  
B: 1 mM DAB-AM-8-iminothiolane-hydrazide. C: 1 mM 
DAB-AM-16-iminothiolane-hydrazide. D: 1 mM PEI-600-iminothiolane-hydrazide.  
E: 0.1 mM PEI-2000-iminothiolane-hydrazide. From the images we can see that the 








several images of the aggregates were taken for each sample. The images were then 
analyzed and percentage of cells in the aggregates of specific size was calculated. 
Results showed that in all the 15 conditions used for this experiment, we could never 
get aggregates of uniform size in the tube. Instead, we could plot out a distribution 
curve for each sample, correlating the percentage of cells in aggregates of specific 
size to the sizes of aggregates, as shown in Fig 2.6. From these curves we can see that, 
for the same kind of chemical linker, percentage of single cells in sample decreases 
and more cells appear in bigger sizes of aggregates as the concentration of linker 
increases, except that for PEI-600-hydrazide, the number of single cells in 0.01 mM 
solution is larger than that in 0.001 mM solution which might due to experimental 
error.  
 
So the answer to the question in the beginning of this part is that we cannot control 
the size of the aggregates in this rotating tube system. However, we can change the 
percentage of cells in aggregates of specific size by fine-tuning the concentration or 
type of chemical used according to these distribution curves. For example, we can use 
0.1 mM PEI-2000-hy in order to make sure over 50% of cells will be in aggregate 
larger than 50 cells
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Fig 2.6 Distribution curves of cells in different sizes of aggregates. Five types of 
chemical linkers were used to aggregate the cells. Phase contrast images were taken 
and analyzed to plot these curves. A: DAB-Am-4-iminothiolane-hydrazide, B: 
DAB-Am-8-iminothiolane-hydrazide, C: DAB-Am-16-iminothiolane-hydrazide, D: 
PEI-600-iminothiolane-hydrazide, E: PEI-2000-iminothiolane-hydrazide. 
Concentrations for A, B, C are 1 mM, 0.1 mM and 0.01 mM whereas for D and E are 









2.6 Live and Dead Assay of aggregates  
It has been proven quite clearly that all of the synthesized chemicals above are 
efficient for aggregate formation. However, in order to prove the feasibility of this 
new system as a possible method for tissue engineering, it is imperative that this 
system is non-toxic to the cells. Because of the importance of carbohydrate residues 
on cell surface, it is possible that the introduction of aldehyde groups to cell surface 
followed by tagging with chemical linkers may compromise many functions of the 
cells. Previous work on surface modification of myoblast cells showed that periodate 
exposure had no gross effect on myoblast cells [146]. Our previous MTS assay also 
tells the cytotoxity of the chemical to unmodified cells. In order to assess the overall 
effect of this gluing system, which includes cell surface modification and aggregation 
provided by chemical linkers, we used the live and dead assay to distinguish the live 
cells from the dead ones, which told us the final viability of the aggregates (Fig 2.7). 
The concentration of all linkers here is 0.1mM. Alive cells were stained with Cell 
Tracker green. The nuclei of dead cells were stained with propidium iodide. In order 
to have a better idea of the viability of cells in the images, we quantified the number 
of alive and dead cells by ImagePro Plus, which is an image processing software and 
got the result in Fig 2.8. Result showed that for DAB series hydrazide, viability of 
cells increases as the concentration of chemical and the number of arms in chemical 
decrease, which agree with previous MTS data. For PEI series hydrazide, the viability 
does not change much when the type and concentration of the chemical used change
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Fig 2.7 Live and dead cells in aggregations. The cells in aggregations were stained by 
CTG, green and PI, red. A: DAB-Am-4-iminothiolane-hydrazide, B: 
DAB-Am-8-iminothiolane-hydrazide, C: DAB-Am-16-iminothiolane -hydrazide, D: 


































Fig 2.8 Quantification of live and dead images in Fig 2.7. Images were processed by 
ImagePro Plus and the curves were plotted according to the calculated results. The 
names of the chemicals were abbreviated as the initial reagent, for example 
DAB-AM-4 here stands for DAB-AM-4-iminothiolane-hydrazide













































2.7 Comparison of the different types of chemical linkers. 
Up till now, we have successfully synthesized several types of chemicals which can 
be used to aggregate cells into multi-cellular structures. However, the mechanism 
underlying this gluing process and further study of the aggregates are pending. 
Considering the possible large amount of workload and time limit, it is impossible to 
work on all five types of chemicals. In addition, since all the five types of chemicals 
are similar in chemical properties, cytotoxicity and aggregation ability from 
preliminary results, it is wise to choose one of them as the model system to study. 
 
Since the aggregates will be the objects for study, the model chemical should be good 
at aggregating cells. Besides this, the aggregates should have high enough viability for 
the multicellular structures to be used in tissue engineering. In order to pick out this 
model chemical, we compared the aggregating ability of the five chemicals as well as 
the viability of aggregates from the chemicals, which are the two important properties 
for characterizing chemicals in this aggregating system. Concentrations of 0.1 mM 
and 0.01 mM were used separately for all five chemicals. In Fig 2.9A, PEI-2000-hy 
PEI-600-hy and DAB-Am-16-hy have better aggregation efficiency than other two 
chemicals. However, the viability of cells in aggregates from 0.1 mM DAB-Am-16 is 
so low (<20%) that it cannot be used for cellular system. In Fig 2.9B, PEI-2000-hy 
has much better aggregation efficiency than other four types of chemicals although 
viability of aggregates from all 0.01mM chemical were more than 70%. Based on
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these, PEI-2000-hy was chosen as the chemical for detailed study in the following 
chapter. 
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Fig 2.9 Comparison of five types of chemicals. Two properties were compared here. 
The blue dots show the viability of cells in aggregates and the red dots show the 
percentage of cells in aggregates the size of which are bigger than five cells. Two 
concentrations were tested here, A is 0.1 mM and B is 0.01 mM. Y-axis here shows 
the percentage of cells. 
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Chapter 3 Engineering Aggregates in a Rapid, 
Non-toxic and Controllable way 
3.1 Aggregation ability characterization of the chemical linker  
3.1.1 Number of hydrazide groups tested by Ellman’s test 
In order to synthesize chemicals which can react with several aldehyde groups on cell 
surface and thereby aggregate cells from individual ones, we designed a two-step 
reaction. In the first step, PEI-2000, which bears around 11 primary amino groups 
reacted with 2-iminothiolane. The product of first step with sulfhydryl groups will 
react with EMCH in the second step reaction. Since PEI-2000 has far more than 1 
primary amino group in the molecule, it is possible to conjugate 2 or more sulfhydryl 
groups, which will be replaced into hydrazide groups by EMCH, resulting in the 
molecules with at least two hydrazide groups. More details of this reaction can be 
found in previous chapter 2.2. 
 
In previous work we tried to use NMR to characterize the structure of the resultant 
molecule and we could conclude that the structure of the product is different from the 
initial reagents. The complex structure of PEI further increases the difficulty to 
characterize its structure by NMR data. So we tried to find an alternative quantitative 
method. Since the intermediate products bear sulfhydryl groups, the Ellman’s test 
[202] which was used to calculate concentration of free thiols, was applied to 
 47
characterize the hydrazide groups indirectly. Based on protocol mentioned in 
“Materials and method”, it was found that there are 3.85 sulfhydryl groups/molecule 
conjugated to PEI-2000 after the first thiolation reaction. It is not a surprising result 
since previous people have found that the use of 2-iminothiolane is an easy way to 
introduce lower amounts of sulfhydryl groups to HAS compared with other method 
[203]. In addition, the branched structure of PEI may hide some primary amino 
groups inside rather than expose them on the chemical surface, which may hinder the 
reaction happening. After EMCH reacted with sulfhydryl groups and replace free thiol 
groups into hydrazide groups at one-to-one ratio, only 0.064 sulfhydryl 
groups/molecule remained. So it was estimated that there were roughly 3.8 hydrazide 
groups on each molecule.  
3.1.2 Formation of aggregates by PEI-2000-hy in a rapid way 
Cell surface engineering used in this research modifies sialic acid into ketone bearing 
one (Fig 2.1). Our original chemicals bear amino groups on the surface. Although 
only a part of the amine groups were transversed into hydrazide groups according to 
Ellman’s test result, the PEI-2000-hy with roughly 3.8 hydrazide groups functioned 
well in aggregates formation. Fig 3.1 shows the phase contrast images of the 
multi-cellular structures and illustrates the specificity of the aggregation ability of 
PEI-2000-hy from modified cells. Both the unmodified and modified HepG2 cannot 
be glued by PEI-2000-hy. The modified HepG2 can form very small clumps by 
PEI-2000, whereas only the modified cells can be glued by the modified PEI-2000-hy 
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Fig 3.1 Aggregation formation of HepG2 cells from PEI-2000-hy. Cells were firstly 
treated by PBS or 1 mM sodium priodate at 4 oC for 15 minutes. Cells were 
resupspended in chemical solution and rotated for 30 minutes. A. Unmodified cells 
suspended in PEI-2000. B. Unmodified cells suspended in PEI-2000-hy. C. Modified 




1 mM 0.5 mM 0.25 mM 0.125 mM 
0.1 mM 5 + 10 5 + 10 5 + 10 10 + 30 
0.05 mM 5 + 10 5 + 10 5 + 10 10 + 30 
0.025 mM 5 + 10 5 + 10 10 + 10 15 + 30 
0.01 mM 5 + 10 5 +20 / 10 + 10 5 + 30 / 15 + 20 > 15 + 30 
 
Table 3.1 The shortest time for formation of aggregates > 10 cells. The first and 
second number shows the incubation time of NaIO4 and linker separately. For 
example, 5+10 means that cells were incubated in NaIO4 for 5 minutes followed by 




efficiently. The clumps of modified HepG2 by PEI-2000 are probably due to the 
unspecific reaction between ketone group and amino groups on cell surface. Actually 
when people used PEI as important materials for gene delivery, they also found that 
bare PEI could also aggregate erythrocyte [204]. 
 
Besides the specificity of PEI-2000-hy to aggregate the modified cell, we also found 
that our new designed chemical is able to form aggregation much more rapidly. 
Comparing with the speed of previous method for aggregation formation by biotin 
hydrazide and avidin with the present new chemical linker, our new method shortens 
the time for aggregation formation from 2.5 hours [205] to as short as 30 minutes. 
Table 1 shows the shortest time for the aggregates of more than 10 cells forming in 
this system. We can see that aggregates can be formed by our method in 30 minutes 
from single cells. This finding stimulates our interest to explore the reason why 
chemical linker such as PEI-2000-hy can act more rapidly in gluing cells.  
3.1.3 Efficiency of this aggregating system 
Previous study has already showed the ability of PEI-2000-hy to glue cells in a rapid 
way. In addition to this, we have to calculate the aggregation efficiency of this 
chemical linking system to make sure the feasibility of using chemical linker for 
aggregating cells. In our experiment, we took 100 images for each sample and count 
the single cells and cells in aggregates one by one. Then we calculated the percentage 
of cells in aggregates, which we named “Aggregation Efficiency”. Although this 
method is not accurate because it becomes more and more difficult to see clearly the 
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number of cells as aggregates increases in size, this provides us a rough idea of the 
approximate percentage of single cells remaining in this rotating system. 
 
From Fig 3.2, we can find that the aggregation efficiency of all the three conditions 
used was above 90%. In addition, there is no significant difference among these three 
conditions although the average value increases as higher concentration of 
PEI-2000-hy was used. Combining this result with previous data, we can conclude 
that by using NaIO4 modification and PEI-2000-hy linkers, we can get 90% of cells 




























Fig 3.2 Aggregation efficiency under different concentration PEI-2000-hy. Cells were 
modified by 0.5 mM NaIO4 for 15 minutes, followed by incubation in different 
concentrations of chemical solution for 30 minutes. 
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3.1.4 Importance of positive charge for PEI-2000-hy as an efficient 
linker 
Initially the reaction between ketone group and hydrazide group was considered the 
key player underlying the formation of cell aggregates. However, this cannot explain 
why PEI-2000-hy act much faster and more efficiently than biotin hydrazide and 
avidin. When we compared the two methods of aggregating cells, we found that one 
and a half hours is required for biotin hydrazide to react with cell surface ketone 
groups, whereas 10 minutes is enough for PEI-2000-hy to aggregate the cells. The 
first possible reason is that PEI-2000-hy has 3.8 hydrazide groups on each molecule, 
whereas biotin hydrazide only has one. However, even we decrease the concentration 
of PEI-2000-hy to one tenth of that of biotin hydrazide, PEI-2000-hy still acts faster 
(data not shown here). So there should be other factors besides covalent reaction 
between hydrazide and ketone groups that play role in aggregating cells. 
 
PEI has been widely used in gene transfection because of the favored interactions 
between negatively charged cell membranes and the positively charged polymer 
surfaces, which enables the polymers to adhere and assist the endocytosis of 
DNA/PEI complexes by cells. These facts provide us a hint that charge may also play 
an important role in the formation of aggregation. In order to find more support for 
this hypothesis, we synthesized another linker with no positive charge but bearing 
four hydrazide groups according to NMR data *. The ability of the chemical to  
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Fig 3.3 Positive charge is necessary of fast formation of the multi-cellular structure by 
chemical linker. A. Neutral linker with 4 hydrazide groups each molecule. B. 
PEI-2000 with no hydrazid groups. C. PEI-2000-hy with about 3.8 hydrazide groups 
each molecule. Only PEI-2000-hy, which is rich in positive charge due to the presence 
of many amino groups and hydrazide groups, is effective glue for modified cells. All 
of the cells were modified with 0.5 mM NaIO4, and the concentration for all the 
chemicals were 0.1 mM. 
* The chemical was kindly synthesized and characterized by Nguyen Thi Thuy Linh 






aggregate cells was compared with PEI-2000-hy, which is highly positively charged. 
Fig 3.3 shows the huge difference of these two types of chemical in their capabilities 
to form aggregates. When the cells were modified to the same extent by NaIO4, 
neutral chemical of the same concentration which has four hydrazide groups cannot 
aggregate cells at all whereas PEI-2000-hy is quite efficient for multi-cellular 
structure formation. This result proves our hypothesis correct. 
3.2 Cytotoxicity of this aggregating system 
3.2.1 Cytotoxicity of modification by NaIO4 
Although we have showed that PEI-2000-hy can be used to aggregate modified cells, 
the cytotoxicity of this system should be studied before it can be used in tissue 
engineering application. Since cells are treated with two types of chemical in this 
system, both of them should be considered for cytotoxicity study. In our present work, 
the method for modifying cell surface is the same as was used previously [205]. 
Because of the importance of cell surface carbohydrate residues, modifying sialic acid 
into ketone groups has the potential to compromise cellular function. Although 
previous work on surface modification of myoblast cells showed that periodate 
exposure had no gross effect on myoblast cells [205]; it is still necessary for us to test 
the toxicity of NaIO4 to HepG2 in our experiment. One reason is that as we change 
the cell type, the effect of chemical on cells may change as well. The other reason is 
that we doubt the sensitivity of trypan blue exclusion as a test for viability of cells 
from previous experience. So instead of using trypan blue test alone, we used three 
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different ways, MTS, trypan blue exclusion, live and dead assay, in order to get 
conclusive result (Fig 3.4).  
 
Fig 3.4A shows the result of MTS data after sodium periodate treatment. From the 
result, we can find that there should be something wrong with this method because it 
showed that the cells treated by PBS had lower reading than the 1 mM NaIO4 treated 
ones. In MTS test, cells were firstly treated with PBS or NaIO4 at 4 oC for 15 minutes. 
It is well known that the cytoskeleton of cells will decompose inside cells at 4 oC, 
resulting in the detachment of cells from substratum. So the number of cells in the 
well incubated with PBS decreased after 15 minutes treatment. However, NaIO4 was a 
strong oxidant and cells treated by NaIO4 on coverslips were found to be hard to be 
washed from substratum. Since MTS reading is highly dependent on the number of 
cells available, it is not hard to explain the strange results. 
 
Our trypan blue results (Fig 3.4B) were quite similar to previous people’s work. When 
the concentration of NaIO4 was lower than 1mM, this treatment showed no significant 
effect on the viability of cells. However, the results from live and dead assay showed 
that even when 0.1 mM NaIO4 was used, there is a significant drop of viability 
(P<0.01) to around 80% according to Fig 3.4C, although there is no significant 
difference among three different concentrations of NaIO4, 1 mM, 0.5 mM and 0.1 mM. 
The low sensitivity of trypan blue test to dead cells can be further proved if we 
compare the results of cell viability after 10mM sodium periodate treatment. Trypan 
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Fig 3.4 Cytotoxicity test of NaIO4 treatment to cells. A is MTS test, which is not 
applicable to this system. B is trypan blue test, which is not sensitive to indicate the 
toxicity of NaIO4. C is live and dead assay which was shown to be the most effective 





blue test showed that around 70% cells were still alive whereas live and dead assay 
showed about 80% of cells were dead.  
 
Based on previous results, we can conclude that trypan blue is not a good way to 
provide the viability data of cells. If we use other more sensitive ways, we can find 
that NaIO4 treatment does affect the viability of cells, which is different from previous 
people’s work. However, we can also conclude that the toxicity of NaIO4 to cells does 
not vary much when the concentration is between 0.1 mM and 1 mM, below which 
sialic acid can be selectively oxidized.  
3.2.2Cytotoxicity of PEI-2000-hy(PEI-2000-iminothiolane-hydrazide) 
Although PEI was widely used in gene transfection and their cytotoxicity was well 
known and tested [208], cytotoxicity of PEI-2000-hy, which was seldom synthesized 
and characterized, has not been tested before. In order to prove the designed chemical 
can be used on HepG2 cells, we used MTS assay to check the cytotoxicity of 
PEI-2000-hy. Cells were incubated in different concentrations of hydrazide solution in 
serum free DMEM for 24 hours followed by incubation with MTS for 3 hours, by 
correlating the number of live cells with the absorption of the resultant solution, we 
calculated the percentage of live cells under different conditions. From results in Fig 
3.5 we can find that when the concentration of chemical is below 0.01 mM, 
PEI-2000-hy possesses little toxicity to HepG2 cells in the experiment condition. 
Since PEI-2000 has about 11 amino groups, the result coincided with previous arts 
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[209] that lysosomal disruption at PEI concentrations above 0.001 M (amines), 
whereas nearly no effects on lysosomal stability when the concentration of PEI is at or 
below 0.0002 M. Considering the fact that concentration of PEI-2000-hy also affects 
the aggregation formation speed according to Table 3.1, we decided to use 
PEI-2000-hy between the concentration of 0.1 mM and 0.01 mM for further study, 
since the viability of the cells is about 80%, which is acceptable if the concentration 
of PEI-2000-hy increases to 0.1 mM.  
 

















Fig 3.5 Cytotoxicity of PEI-2000-hy. The cytotoxicity of chemicals was tested by 
MTS assay. The viability of the cells was calculated based on the absorption of the 
resultant solution. 
 
3.2.3 Live and Dead Assay of the Aggregates 
Although we have characterized the cytotoxicity of NaIO4 and PEI-2000-hy to HepG2 
cells in this engineering system, both of the tests were performed independently of 
each other. The NaIO4 treatment of cells was not followed by incubation with 
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PEI-2000-hy, which may further increases the toxic effect on cells. MTS test of 
PEI-2000-hy was done on natural cells without modification, which cannot represent 
the effect of linker on modified cells. In addition, the aggregates were produced in a 
rotating tube system, the effect of which cannot be represented by previous 
cytotoxicity test. In order to get complete information about the cytotoxicity of this 
system, we must find another way to test the viability of cells in aggregates after all of 
the chemical and engineering processes. Staining cells with CellTracker Green and PI, 
as we named live and dead assay was used to quantify the overall viability of cells in 
aggregates. CellTracker dyes are thiol-reactive fluorescent dyes and they can freely 
diffuse into the cell, where its weakly thiol-reactive moieties react with intracellular 
thiols, generating the green fluorescent product. Propidium iodide can only enter 
damaged cell membranes and undergoes a fluorescence enhancement upon binding to 
nucleic acids, promoting a red fluorescence in dead cells only. Stained cells can be 
observed and imaged using CLSM as shown in Fig 3.6. 
 
We used 0.5 mM NaIO4 to modify cells, followed by treated with 0.1 mM, 0.05 mM 
and 0.01 mM PEI-2000-hy respectively. The control cells were treated with PBS but 
using the same rotating system. In order to quantify the viability of cells, ten random 
areas of view were taken and processed by ImagePro Plus. The cell viability was 
calculated based on the number of live and dead cells. Results in Fig 3.7 tell us that 
even the cells were treated by PBS in rotating tubes; the average viability of cells 




Fig 3.6 Live and dead assay of aggregates from PEI-2000-hy. Live cells were stained 
by cell tracker green and dead cells were stained by PI. The images were taken by 
confocal laser scanning microscopy FV 300. Cells were modified by 0.5mM NaIO4, 





















Fig 3.7 Quantification of Live and Dead assay in Fig 3.6. Ten random areas of view 
were taken and were processed by Imagepro Plus. The cell viability calculated as the 
mean ± SEM of three experiments. 
 
treated by 0.5 mM NaIO4 followed by 0.01 mM PEI-2000-hy, the average viability of 
cells reduces to around 75%, which coincidence with previous data the 0.5 mM 
NaIO4 treatment results in 80% viability of cells in Fig 3.4C. In addition, there is not 
significant difference between this condition and control. When the concentration of 
PEI-2000-hy increases to 0.05 mM, the viability of cells drops significantly to less 
than 60%.  
 
Based on the above results, we can conclude that the rotating system also contributes 
to the death of cells during aggregates formation. We can find out some condition by 
adjusting the concentration of chemical linkers to minimize the overall cytotoxicity of 
the system. 
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3.2.4 Culture of the aggregates 
After we were able to engineer aggregates in a fast, efficient and low-toxic manner, 
we have to answer several questions before this system can be used for long-term 
application. For example, how can we culture the aggregates? How does the 
engineering process affect the long term viability of the cells? Is the proliferation 
ability of the cell line affected?  
 
Based on previous results, we chose the condition of 0.5 mM NaIO4 and 0.01 mM 
PEI-2000-hy. We tried to answer the three questions above by culturing the aggregates 
in suspension up to 7 days. During the initial stage of this work, we even tried to 
culture the aggregates in bacterial culture dish and negatively-charge dish, both of 
which have low adhesion to cells. However, we found that the aggregates still adhered 
to the substratum and spread as normal cells. Later on, we cultured the aggregates in 
suspension by keeping them rotating. After we optimized the rotating speed at which 
the aggregates would not fall down, we decided to culture the aggregates in the plate 
on the rotating machine. When we observed the phase contrast images of aggregates 
taken on different days as they were cultured in suspension (Fig 3.8); we find that the 
cells in aggregates tend to grow compact and even grow into spheroid structure with 
smooth surface on the second or the third day. These phenomena are quite similar to 
those observed from natural aggregates from rotating system in our experiment (data 
not shown here), which hints the tendency of the engineered aggregates growing from 
engineered ones to natural ones.  
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In order to assess the viability changes of the aggregates in suspension culture, we 
characterized it by live and dead assay (Fig 3.9 & 3.10). Quite promisingly, we found 
that although the initial viability of the aggregates is only around 70%, which may not 
be satisfying in many biologists’ opinion, the viability of the aggregates started to 
increase in suspension culture. After 7 days culture, the viability of cells in aggregates 
is about 95%. The increase of viability may be due to the proliferation of live cells. 
From the live and dead images, we can also find that there are fewer and fewer dead 
cells in the aggregates, which may also because of the detachment of dead cells from 
aggregates. 
 
Besides Live and Dead assay, we also use MTS to test the mitochondrial activity of 
multi-cellular structure, which is one of the functional tests for cells. Curves in Fig 
3.11 show quite promising result that the mitochondrial activity of aggregates also 
increases according to time. Both the increase in number of cells and in mitochondrial 
activity of single cells can contribute to this positive result.  
 
Up till now, we are still not sure about the exact reason for increase of viability and 
MTS test data. However, we can find that the toxic effect of the engineering system 
on cell aggregates does not long as they are cultured in suspension, although the cells 
were treated with NaIO4 and PEI-2000-hy in an unfavorable rotating system. By 
taking advantage of this fast, efficient and low-toxic aggregating approach as well as 
this suspension culture system, we maybe able to engineer aggregates with defined 
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Fig 3.8 Phase Contrast images of the aggregates on different days during culture in 
suspension up to 7 days. Cells were modified by 0.5 mM NaIO4 for 15 minutes at 4 
oC in dark, followed by in incubating in 0.01 mM PEI-2000-hy in rotating tubes for 
30 minutes. Aggregates were cultured in 6-well plate on rotating shaker. Images were 
taken on different days. A, B: 100 X and 400 X images on day 0; C, D: 100 X and 400 
X images on day 1; E, F: 100 X and 400 X images on day 2; G, H: 100 X and 400 X 
images on day 3; I, J: 100 X and 400 X images on day 5; K, L: 100 X and 400 X 
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Fig 3.9 Live and Dead assay for culture of aggregates. The cells were modified with 
0.5 mM NaIO4 at 4 oC for 15 minutes followed by linked with 0.05 mM PEI-2000-hy. 
Cell aggregates were cultured in suspension up to 7 days.  Cells in aggregates were 
stained with CTG and PI. Live and dead images taken by Confocal microscopy 
































Fig 3.10 Quantification of images in Fig 3.9. Data were analyzed with ImagePro Plus. 
Three sets of experiment were done to make sure the feasibility of the results. 
 

























Fig 3.11 MTS data of cell aggregates in suspension culture. Data are presented as 






shape and advanced functionality for tissue engineering application. 
 
Since viability and mitochondrial activity are only two aspects of biological 
characteristics, functionality such as albumin secretion of HepG2 cells in aggregates 
can be studied in next phase. In addition, the cellular mechanism underlying this 
phenomenon also requires further exploration. Are the chemical linkers still on the 
cell surface after several days? Is there any up-regulation of cell adhesion molecules 
stimulated by signals proved by neighbor cells? Can we find other ways to aggregate 
the cells without modification? How can we control the shape and size of the 
multi-cellular structure? All of these are important topics to study to further validate 
the feasibility of this new system. 
3.2.5 Fate of chemical linker  
3.2.5.1 Observation of fluorescence- chemical linker on cell surface  
Up to now, we have proved that by taking advantage of the positive charge and 
covalent reaction between ketone and hydrazide groups, we were able to aggregate 
cells in a rapid, efficient and low toxic way. In addition, the chemicals bear no adverse 
effect on the cells viability and functionality in culture. However, both aggregation 
formation process and the mechanism underlying the increased viability of aggregates 
are still unrevealed to us. We may be able to understand more about the system if we 
could observe the chemical linker directly. In order to achieve this goal, fluorescence 
tag was conjugated to PEI-2000-hy through the reaction between ester and amino 
groups. Similar method was used to track the intracellular fate of poly 
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(ethylenimie)/DNA complexes for gene delivery [206]. Un-reacted Oregon Green 
ester was removed by dialysis. Fluorescence linker was used in the same way as 
normal PEI-2000-hy to glue the cells. In the reaction, PEI-2000-hy was firstly 
synthesized followed by tagging with Oregon Green. Although the reaction capability 
between hydrazide and ester is higher than that between amine and ester in neutral or 
acidic buffer, the synthesized PEI-2000-hy only contains 3.8 hydrazide and more than 
7 amine groups [207]. So the chance for ester to react with amine groups is still very 
high. Although we don’t have data to show that the fluorescence tag is indeed on 
amine group instead of hydrazide group, aggregation data showed that the 
fluorescence linker can also aggregate the cells efficiently (not shown here). Since the 
purpose of synthesizing the linker is to track the fate of the linker on cell aggregates, 
we don’t care much about which functional group the fluorescent probe is conjugated 
to as long as the linker can both aggregate the cells and shows fluorescence under 
confocal microscopy.  
 
After cells were aggregated by the fluorescence-tagged-PEI-2000-hydrazide, we 
washed the aggregates with PBS buffer and observe them directly with confocal 
microscopy (Fig 3.12A). We find that most of the fluorescence enclosed the cell 
surface into a ring. However, some of the linkers were also inside cells. We thought it 
might be due to the endocytosis of cells. In order to further distinguish live and dead 
cells in aggregates from fluorescent linkers, we dually stained the cells with Cell 
Tracker Blue and PI. Images showed that both live and dead cells were enclosed by 
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Fig 3.12 Fluorescence linker observed by Olympus Fluoview 500. A: The green color 
on the cell surface is the fluorescence linker. B: Live cells were stained with Cell 
Tracker blue and dead cells were stained with PI so that we can see all of the cells 
were enclosed by green color, which is from Oregon Green tagged-PEI-2000-hy. A: 
Cells were not stained. Only the fluorescence linker can be observed. B. Cells were 







linkers (Fig 3.12B).We can also see that most of the cells in aggregates are still alive,   
making it possible to track the fate of fluorescence linker in aggregates during culture 
in later study. 
 
3.2.5.2 Tracking the chemical linker in suspension culture 
In order to find out the mechanism underlying the increased viability of cell 
aggregates in suspension culture, we cultured the aggregates formed by fluorescence 
linker, using the same aggregation and culture system as above, only changing the 
normal PEI-2000-hy into Orgen Green tagged PEI-2000-hy. In negative control 
experiment, we found that, if all of the cells in aggregates were dead (by fixation), the 
fluorescence linker will continue to stay on cell surface during 7 days culture (data not 
shown here). We stained the aggregates with Cell tracker Blue and PI in order to make 
sure most of the cells are alive after the cells were modified by 0.5 mM NaIO4 and 
aggregated with 0.05 mM fluorescent linkers (Here we changed the concentration 
because preliminary data showed that we can hardly get clear images of fluorescence 
if 0.01 mM fluorescent linker was used).  
 
From Fig 3.13 we can find that on Day 0, the fluorescence is clearly distributed on 
cell surface and enclosed the cell to a ring. The fluorescence keeps disappearing from 
cell surface according to the images taken on different days and some of the cells even 
endocytosed the linker into the cells. From Day 5 on, there is almost no fluorescence 
linker on the cell surface or inside the cells. In order to get a clearer idea of the fate of 
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Fig 3.13 Fate of chemical linker on cell surface in culture. Cells were dually stained 
by Cell-tracker blue (live cells) and PI (dead cells). Linker can be directly observed. 
Images were taken on different days. A. Day 0. B. Day 1. C. Day 2. D. Day 3. E. Day 


































Fig 3.14 Quantification of amount of fluorescence remaining on cell surface. Images 
in Fig 3.13 were quantified by ImagePro Plus. 
 
fluorescent linker on the cell surface, we quantified the images using ImagePro Plus 
(Fig 3.14). Compared with control, in which the cells in aggregates were killed, we 
can see that the disappearance of fluorescent linkers is because of the cellular activity 
instead of the properties of the linkers. This result stimulates our further interest to 
stain the cell adhesion molecules on the cell surface, which may be responsible for 
gluing the cells after chemical linkers disappear. 
3.3. Ability of controlling aggregates using chemical linking system 
3.3.1 Control the size distribution by linker concentration changes. 
The advantage of our system is that aggregates can form in rapid, efficient and 
low-toxic way. So if we could define the structure of the multi-cellular strucuture, we 
might be able to achieve functional structures with proper structure. However, from 
discussion in previous chapter, we already know that aggregates formed in this tube 
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rotating system are not uniform in size or shape. What we can do in this system is to 
control the size distribution of aggregates by varying concentration of chemical 
linkers. So the distribution curve is quite useful when we want to collect aggregates of 
specific sizes. Based on this, using the same method as previous chapter, we plotted 
the aggregates distribution curve of PEI-2000-hy at 0.05 mM and 0.01 mM separately 
(Fig 3.15). From this Fig, we can find that when 0.01 mM PEI-2000-hy was used, 
more than 50% cells formed aggregates smaller than 30 cells, whereas, around 60% 
cells appeared in aggregates larger than 50 cells if 0.05 mM PEI-2000-hy was used. 
These distribution curves could be used as indicators when we want to get specific 
sizes of aggregates. However, in both situations, we cannot get aggregates of the same 
size, not to mention the defined structure. 




























Fig 3.15 Distribution curves of the sizes of aggregates from PEI-2000-hy. Two 
concentrations were compared, 0.01 mM and 0.05 mM. The percentage of cells in 
specific size of aggregate changed when the concentration of chemical linker changed. 
More than 50% cells were in sizes < 30 cells for 0.01 mM PEI-2000-hy, whereas, 
fewer than 30% cells were in sizes < 30 cells when 0.05 mM PEI-2000-hy was used, 
in which most cells (more than 60%) formed aggregates > 50 cells.  
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3.3.2 Manipulating cells into defined structure by stenciling and 
micromanipulation 
Previous data has shown that we can change the size distribution of aggregates by 
changing the concentration and type of chemical linkers, but we could never be able 
to achieve multi-cellular structure of uniform size in this rotating tube system. As can 
be seen from phase contrast images, the shapes of the aggregates are random as well, 
which are mostly like branches or grapes. In order to achieve standard building blocks 
for tissue engineering, we used micropatterning and micromanipulation to control the 
size and shape of the multi-cellular structure. In our experiment, we were able to 
pattern multi-cellular structure by stenciling (Fig 3.16A) as well as define the shape 
more precisely with micromanipulation (Fig 3.16B), which hinted us the possible use 
of this system in precisely manipulating cells into 3D structures. It will not only assist 
the research on relationship of structure and function, but also provided a novel way 
to reconstruct tissue in vitro. The reason why micropattern can be used to control the 
shape of the aggregates is because cells can be glued very fast and efficiently using 
our system. If it took longer time, the cells might adhere to the PDMS substratum 
instead of sticking to each other. Aligning cells by micromanipulation cannot be used 
for other aggregating methods either. Because it is impossible to hold two cells 
together until they stick to each other after several hours. 
 
However, there are still several problems for both methods. The problems involved in 
stenciling include, firstly, difficulty in getting a complete thin layer of PDMS because 
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of the fragility of the PDMS layer; secondly, difficulty in peeling off the layer from 
substrate with the cell aggregates intact. The main problem for micromanipulation is 
that the whole process took such a long time that it is rather difficulty to keep the 
viability of cells. Further work is required before better conditions are worked out to 




Fig 3.16 The structure of the aggregates can be controlled by stenciling or 
micromanipulation. 
A. PDMS film with diameter of 50 µm circles were molded from silicon wafers. 
Modified cells (by 1 mM NaIO4) settle down into the holes and incubated in the 
chemical solution for 30 minutes. After the PDMS film was peeled off, cell 
aggregates in round shape remained on the substrate.  
B. Cells were modified by 1 mM NaIO4 for 15 minutes. With the presence of 
PEI-2000-iminothiolane-hydrazide at the concentration of 0.1 mM, cells were glued 
with single cell resolution with the aid of micromanipulation. Images were taken by 








Chapter 4 Conclusion and Future Work 
Although cell aggregates has been used since several decades ago as a powerful tool 
for understanding cell-cell adhesion, cell-matrix interaction and cell sorting, not until 
recently have the cell aggregates been treated as building blocks in tissue engineering. 
Previous work has been done to prove the concept of self-assembling of aggregates, 
which justified the use of cell aggregates in organ printing to create 3-D tissues. 
However, an efficient and controllable way to build cell aggregates is still lacking. 
Using 2-step chemical conjugation reaction, we successfully synthesized two series of 
chemical linkers with poly (ethyleneimine) and dentrimers as the initial reagent 
separately. All of the five types of linkers can glue the cells efficiently and 
specifically.  
 
In order to further prove the feasibility of this chemical linking system in the area of 
tissue engineering, we need to sort out a sample chemical to prevent repeating work 
and heavy workload. Aggregation efficiency and viability of aggregates from the 
linkers were used as two parameters to justify choice of PEI-2000-hy. By working 
deeper into this aggregating system using PEI-2000-hy as a model, we found that the 
way to use chemically controlled linker to build multi-cellular structures is faster 
compared with previous biotin hydrazide and avidin method. We also discovered that 
the charge interaction between the linker and the negatively charged cell surface is as 
important as the covalent nature of chemical reactions. Under the guidance of this 
 77
principle, we could find an optimal condition that would form multi-cellular structure 
efficiently and keep relatively good viability. In addition, we found the cells in the 
aggregates showed increased viability over time in suspension culture although the 
initial viability is not promising enough. With the help of fluorescence tag, we find 
that the fluorescence linker gradually disappeared from cell surface as aggregates 
were cultured, when the aggregate became more compact. This stimulated our interest 
into studying the fate of cell adhesion molecule to understand the mechanism 
underlying these phenomena. 
 
However, it was found that the shape and size of the aggregates could not be 
controlled by this random-rotating system. In order to really engineer aggregates with 
defined shape and size, we applied microstenciling and micromanipulation to control 
the shape of the multi-cellular structures. The interesting preliminary results validated 
the possible application of this system into contructing functional 3-D tissues in vitro.  
 
Despite the promising results above, there are some inherent problems in this 
chemical linking system. Firstly, sodium periodate treatment of sialic acids into 
ketone sialic acids on cell surface does affect the viability of the cells, from the result 
we have got. It is imperative to find alternative way to treat the cells more gently in 
order to reduce the adverse effect of the engineering process on cells. Secondly, the 
mechanism underlying the aggregating process has not been clarified; although we 
have found out the importance of covalent binding and positive charge the linker 
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provides, the kinetics is still a mysterious. Thirdly, although the aggregates could 
restore viability in continual culture, it usually took several days to achieve this. The 
system will have more application if we could find ways to shorten the recovery time 
of aggregates. In addition, HepG2 is a kind of cell line which keeps proliferating, 
which contributes to the increased viability of aggregates. So whether similar result 
can be achieved on non-proliferating cells such as primary hepatocytes is still a 
question. Last but not the least one, although we managed to control the size and 
shape of the multi-cellular structures by micropatterning and micromanipulation, how 




















Chapter 5 Materials and Methods 
All reagents were purchased from Sigma-Aldrich unless stated otherwise. 
5.1 Cell culture 
HepG2 cells (ATCC, VA, US) were cultured in 75 cm2 tissue culture flask (NUNC, 
Denmark) with Dulbecco’s modified Eagle’s medium (GIBCO, Invitrogen,) 
supplemented with 10% fetal bovine serum (Hyclone, Utah, US), 1.5 g/L glucose, 100 
units/mL penicillin, 100 g/mL streptomycin, 1.3 g sodium bicarbonate and 1.2 g 
Hepes (Gibco BRL, Life technology, Maryland, US). The cells were cultured at 37oC 
in a humidified environment with 5% CO2.                                
5.2 Determination of surface modification by NaIO4 on HepG2 cell 
surface 
Coverslips were put into 24-well tissue culture plate (NUNC, Denmark). HepG2 were 
grown into confluence on the coverslip, washed twice with phosphate-buffered saline 
(NUMI, National University of Singapore) at room temperature and incubated in the 
dark at 4 °C for 15 min with cold PBS or a solution of sodium periodate in cold PBS. 
Wash cells with biotin buffer (PBS with 0.1% FCS, pH = 6.5) twice, followed by 
incubating them in 5 mM biotin hydrazide (dissolved in biotin buffer) at room 
temperature for 90 minutes. Wash cells with cold avidin buffer twice (PBS with 0.1% 
FCS, pH = 7.4). Then treat cells with Streptavidin-FITC (5 µg/ml, Dako, Denmark) 
for 20 minutes at 4 °C in the dark. Cells surface fluorescence was then analyzed by 
 80
fluorescent confocal microscopy (Olympus Fluoview 300) with the magnification of 
400 X. The excitation wavelength is 488 nm. 
5.3 Synthesize of the chemical linkers 
4-DAB-Am-hydrazide:  
8 mg 4-DAB-AM (Mw=316, 25 µmol) was added to 2-iminothiolane (15 mg, 
Mw=137.6, 100 µmol) in distilled-water (2 ml) at room temperature. The mixture was 
stirred for 2 hr. EMCH (22.5 mg, 100 µmol, Pierce, IL, US) was added in DMSO 
(0.5-1 ml, J.T. Baker, NJ, US.) to react for 4hr. The finally product was isolated by 
eluting it through a PD-10 column (Amersham Pharmacia Biotech AB Piscataway, NJ, 
US.) with distilled-water, freeze-dried 48hr. 
 
8-DAB-Am-hydrazide:  
8 mg 8-DAB-Am (Mw=773, 12.5 µmol) was added to 2-iminothiolane (15 mg, 
Mw=137.6, 100 µmol) in distilled-water (2 ml) at room temperature. The mixture was 
stirred for 2 hr. EMCH (22.5 mg, 100 µmol) was added in DMSO (0.5-1 ml) to react 
for 4 hr. The finally product was isolated by eluting it through a PD-10 column with 
distilled-water, freeze-dried 48 hr. 
 
16-DAB-Am-hydrazide:  
11 mg 16-DAB-Am (Mw=1686.6, 6.5 µmol) was added to 2-iminothiolane (13.5 mg, 
Mw=137.6, 100 µmol) in distilled-water (2 ml) at room temperature. The mixture was 
stirred for 2 hr. EMCH (22.5 mg, 100 µmol) was added in DMSO (0.5-1 ml) to react 
for 4 hr. The finally product was isolated by eluting it through a PD-10 column with 
distilled-water, freeze-dried 48 hr. 
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PEI-600-hydrazide:  
15 mg PEI-600 (Mw=600, 25 µmol) was added to 2-iminothiolane (12.5 mg, 
Mw=137.6, 90 µmol) in distilled-water (2 ml) at room temperature. The mixture was 
stirred for 2 hr. EMCH (21 mg, 90 µmol) was added in DMSO (0.5-1 ml) to react for 
4 hr. The finally product was isolated by eluting it through a PD-10 column with 
distilled-water, freeze-dried 48 hr. 
 
PEI-1200-hydrazide:  
15 mg PEI-1200 (Mw=1200, 12.5 µmol) was added to 2-iminothiolane (25 mg, 
Mw=137.6, 180 µmol) in distilled-water (2 ml) at room temperature. The mixture was 
stirred for 2 hr. EMCH (40 mg, 180 µmol) was added in DMSO (0.5-1 ml) to react for 
4 hr. The finally product was isolated by eluting it through a PD-10 column with 
distilled-water, freeze-dried 48 hr. 
 
PEI-2000-hydrazide:  
20 mg PEI-2000 (Mw=2000, 10 µmol) was added to 2-iminothiolane (15 mg, 
Mw=137.6, 110 µmol) in distilled-water (2 ml) at room temperature. The mixture was 
stirred for 2 hr. EMCH (25.6 mg, 110 µmol) was added in DMSO (0.5-1 ml) to react 
for 4 hr. The finally product was isolated by eluting it through a PD-10 column with 
distilled-water, freeze-dried 48 hr. 
5.4 Characterization of the chemical linkers – Ellman’s test 
In an appropriate cuvette (Plastibrand®, BRAND, Germany), add 50 µl of the DTNB 
solution (50 mM sodium acetate (NaOAc) with 2 mM DTNB in H2O (refrigerate, 
DTNB is 5, 5’- Dithiobis (2-nitrobenzoic acid), Molecular Probes, CA, US), 100 µl 
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Tris solution, and water up to (1000µl – sample µl). Mix solution carefully using 
pipette. Place cuvette into UV-Vis spectrophotometer (UV-1201, Shimadzu, Japan) 
and take a background scan using the solution as background. Introduce sample 
solution into cuvette with a syringe, keeping the cuvette in the instrument. Carefully 
mix solution with a pipettemen without disturbing the cuvette. Incubate 5 min at room 
temperature. Scan sample and record Absorbance at 412 nm. Calculate absorbance for 
each sample and then average the results, divide this by 13600 M-1 cm-1 (the 
extinction coefficient of the reagent) to get the molarity of the solution. After 
PEI-2000 reacts with 2-iminothiolane for 2 hr, product was eluted by PD-10 column. 
The amount of free thiol group on PEI was tested by Ellman’s test. The first step 
product was put back together with EMCH to react another 4 hrs. Final product was 
eluted through PD-10 and the remaining free thiol group was tested again. By 
comparing the amount of thiol groups on the products of two steps, the number of 
hydrazide group on each PEI molecule was estimated.  
5.5 Cytotoxicity test of the chemical linkers 
Culture HepG2 cells on 96-well microtitre plates (Nunc, Denmark) at a density of 1.2 
× 104 cells/well.  Incubate for 24 hours, remove medium and add the chemical 
solutions in serum free medium at different concentrations (0.1 µM, 1 µM, 10 µM, 
100µM, 1mM), with a final volume of 200 µl. After 24 hours of incubation, the 
medium was removed and the cells were rinsed by 160 µl sterile PBS for twice. 200 
µl CellTiter96 ® Aqueous One Solution Reagent (Promega, Madison, USA) diluted 
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by 5 times PBS was added to each well. After incubation for 3 hours, the absorbance 
will be measured at 490 nm using a SunriseTM microplate absorbance reader [Tecan, 
Switzerland]. 
5.6 Synthesis of fluorescence PEI-2000-hy 
PEI-2000-hy synthesized as described above was diluted to a concentration of 10 
mg/ml with 0.1 M sodium bicarbonate. The PEI-2000-hy was then transferred to 
microcentrifuge tubes (Axygen, Union City, CA, US) in 1-ml aliquots. While stirring, 
50 ml of prepared tag [Oregon Green 488 carboxylic acid, succinimidyl ester 
(Molecular Probes), in DMSO at 10 mg/ml] was added to each of the microcentrifuge 
tubes, after which stirring continued for 1 hour in the dark at room temperature. The 
stirring was then followed by an additional incubation of at least 1 hour in the dark. 
Unreacted fluorescence probes were removed by Spectra/Por® Cellulose Ester (CE) 
dialysis membranes with MWCO 1000 (Spectrum Laboratories, Inc, CA, USA). The 
labeled PEI could then be used for aggregation or stored at 4°C.  
5.7 Cytotoxicty of NaIO4 on cells 
1. MTS assay of cells treated by NaIO4 
Culture HepG2 cells on 96-well microtitre plates (NUNC, Denmark) at a density of 
1.2 × 104 cells/well.  Incubate for 48 hr; remove medium and wash cells with 1 X 
PBS twice. Different concentrations of NaIO4 (10 mM, 5 mM, 1 mM, 0.5 mM, 0.1 
mM and PBS) were used to incubate cells in dark at 4 oC for 15 minutes. Cells were 
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then washed with PBS twice again and incubated in CellTiter96 ® Aqueous One 
Solution Reagent (Promega, Madison, USA) solution diluted 5 times by PBS for 3 
hours in normal culture environment. The absorbance will be measured at 490 nm 
using a SunriseTM microplate absorbance reader [Tecan, Switzerland]. 
 
2. Trypan blue assay of cells  
Cells were cultured in 75 cm2 tissue culture flask (NUNC, Denmark) in the same 
medium mentioned above. The cells in flask were washed with phosphate-buffered 
saline twice at room temperature. Cells were suspended by incubation with 3ml 
pre-warmed Trypsin/EDTA solution at 37 °C. Trypsin was neutralized with DMEM 
medium and the cells were centrifuged at 800 g for 2 minutes. Cell pellets were 
washed twice with PBS, pelleted and resuspended in cold PBS or different 
concentrations (10 mM, 5 mM, 1 mM, 0.5 mM, 0.1 mM) of sodium periodate solution. 
After incubation at 4 °C in dark for 15 minutes on rotary shaker, cells were pelleted 
and washed with cold PBS twice. The final cell pellet was resuspended and incubated 
with trypan blue solution (Fluka, Switzerland) for 5 minutes. The cells were then 
imaged using microscope equipped with an Olympus IX50 microscope. Cells were 
counted in a cell counter [Hirschmann EM techonology]. Four random fields of view 
were counted per assay condition, and the cell number and viability calculated as the 




3. Live and dead assay of cells  
HepG2 cells were cultured, trypsinized, pelleted, washed with PBS and incubated 
with PBS or sodium periodate solution using similar method mentioned above. Cells 
were then washed with PBS twice and dually stained with CellTracker™Green (CTG, 
Molecular Probes, CA, US) and propidium iodide (PI). The cells were resuspended in 
double staining solution (50 µmol/ml CTG and 25 µg/ml PI in DMEM). Incubate for 
30 minutes at 37 oC. Wash the cell with PBS another twice. Put the cells on ice until 
observation by fluorescent confocal microscopy (Olympus Fluoview 500). CTG was 
observed at the wavelength of 488nm and PI was at 543nm. Images were analyzed by 
ImagePro Plus and viability of the cells was calculated based on the number of live 
cells and dead cells which were counted separately by the software on at least 10 
images for each sample. The result was calculated as the mean ± SEM of three 
experiments 
5.8 Formation of cell aggregates by modified cells and chemicals 
HepG2 cells were cultured and trypsinized using similar method mentioned above. 
Then the cells were centrifuged at 800 g for 2 minutes. Cell pellets were washed twice 
with PBS, pelleted as described above and resuspended in cold PBS or sodium 
periodate solution. After incubation at 4° C in dark for 15 minutes, cells were pelleted 
and washed with cold PBS twice. Chemical linkers with specific concentration were 
added and cells were kept in rotation to prevent from settling down. Pipet 
approximately 25 µl of the cell suspension into 12-well plate (NUNC, Denmark) and 
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dilute it with 1 ml PBS after 35 minutes incubation at 4 °C. Observe the aggregation 
by phase contrast light microscope (Olympus IX50) at the magnification of 100 X. 
5.9 Statistics on aggregates size distribution 
After the aggregates were formed, 500 ul of the cell suspension was taken out and put 
into 12-well plate. The images on aggregation were taken by phase contrast light 
microscope. Then counting was carried out on the images. The number of individual 
cells, the number of aggregates as well as the number of cells in each aggregate was 
counted according to the image taken. The percentage of cells in aggregates was 
worked out based on those data. 
5.10 Live and dead assay of the aggregates 
Cell aggregates were loaded into 8-well chamber (LapTek; Nunc, Naperville, IL) and 
allowed to settle down. Remove the supernatant and wash the aggregates with cold 
PBS twice. Resuspend the cell aggregates in double staining solution (50 µmol/ml 
CTG and 25 µg/ml PI in Dulbecco’s modified Eagle’s medium). Incubate for 30 
minutes at 37 oC. Wash the cell aggregates with PBS another twice. Fix the cell 
aggregates with 3.7% PFA for 30 minutes at 37 oC. Then wash with PBS twice and 
keep the cells in PBS until observation. Images of cell aggregates were taken by 
fluorescent confocal microscopy (Olympus Fluoview 500) at the magnification of 
200X. CTG was observed at the wavelength of 488 nm and PI was at 543 nm. Images 
were analyzed by ImagePro Plus and viability of the aggregates was calculated based 
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on the number of live cells and dead cells which were counted separately by the 
software. The cell number and viability were calculated as the mean ± SEM of three 
experiments. 
5.11 Culture of cell aggregation 
After aggregation formation, chemical linkers were removed from supernatant. 
Culture medium was added into aggregates pellets. Resuspend the aggregates in 
Dulbecco’s modified Eagle’s medium with all the necessary additions as mentioned 
previously and culture them in 6-well tissue culture plate (NUNC, Denmark) on top of 
rotary machine (Spectra-teknik, US) at the speed of 50 rpm at 37 oC in a humidified 
environment with 5% CO2. 
5.12 MTS assay of the aggregates 
Centrifuge aggregates at 800 g for 1 minute. Washed the pellet once with 1X PBS. 
Add 2 ml of 37 ºC CellTiter96 ® Aqueous One Solution Reagent (Promega, Madison, 
USA) (5 X dilution in PBS) into the tube, and transfer the solution into a 12-well plate. 
Incubate at 37 ºC for 3 hr in the dark on the rotary machine (Spectra-teknik, US). 
Transfer the solution into a 1.5 ml tube. Spin down at 4 ºC, 800 rpm for 2 minutes. 
Remove 100 µl of MTS solution into 96-well plate for absorbance reading at 490 nm 
using a SunriseTM microplate absorbance reader [Tecan, Switzerland]. Track the fate 
of chemical linker by fluorescence tagged PEI-2000-hy. 
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5.13 Track the fate of chemical linker by fluorescence tagged 
PEI-2000-hy 
Aggregates were formed using 0.05 mM Oregon green-tagged PEI-2000-hy on 
HepG2 cells modified by 0.5 mM NaIO4. Aggregates were dually stained with 
CellTracker™ Blue CMAC (CTB) and PI (50 µmol/ml CTG and 25 µg/ml PI in 
Dulbecco’s modified Eagle’s medium) to distinguish live and dead cells. Aggregates 
were cultured using the same way as mentioned above. Fluorescence of the linker can 
be directly observed using Olympus Fluoview 500 at the excitation wavelength of 488 
nm. CTB was observed at the wavelength of 412 nm and PI was at 543 nm. Images of 
the fluorescence on different days were taken and exported to the image processing 
program of ImagePro Plus. The fluorescence intensity was calculated and divided by 
the number of cells in the image, resulting in the average fluorescence intensity per 
cell.  
5.14 Micropatterning  
The method mentioned in previous literature [210] was used to fabricate the reusable 
PDMS film with holes. The PDMS film are fabricated by casting and curing an 
elastomeric polymer, Sylgard 184 (Dow Corning, MI, US), against a photoresist 
micropatterned silicone master, which was kindly provide by Khong Yuet Mei and Ng 
San San from Graduate Program in Bioengineering at NUS. Both the diameter and 
depth of the circle is 50 µm. PDMS film was applied to the surface of tissue culture 
dish (NUNC, Denmark) and sealed simultaneously against the surface. Cells were 
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modified by 1 mM NaIO4 at 4 oC in dark for 15 minutes and suspended in PBS 
followed by seeding onto the culture dish. PDMS film prevented the cells from 
attaching to the surface of dish except on the holes area. After a few minutes, the cells 
settled down into the holes. Then chemical linker solution (1mM PEI-2000-hy) was 
poured onto the surface and the cells were incubated in solution for 30 minutes. After 
the PDMS film was peeled off, circular multi-cellular structure remained on the dish 
and the structure was rather stable which could sustain the wash of PBS. Images were 
taken by confocal laser scanning microscopy (Olympus Fluoview 300). 
5.15 Micromanipulation 
Microcapillary with the tip diameter of around 10 µm is used to manipulate the 
HepG2 cells. Cells were modified by 1 mM NaIO4 at 4 oC in dark for 15 minutes and 
suspended in 1 mM PEI-2000-hy. Cell suspension was transferred into a tissue culture 
dish (NUNC, Denmark). Micromanipulator (Eppendorf 5171, Hamburg, Germany) 
and CellTram (Eppendorf, Air) were used to manipulate the HepG2 cells into defined 
structure. Images were taken by confocal laser scanning microscopy (Olympus 
Fluoview 300). 
5.16 Statistical analysis 
Statistical calculations were carried out by function of T-Test in Microsoft Excell. All 
values are presented as the mean +standard deviation unless otherwise noted. 
Probability values P<0.05 were considered significant. 
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